CCEL Q2 2021 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q2 2021 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$7M-8.5% YoY

Gross Profit

$5M69.2% margin

Operating Income

$2M27.7% margin

Net Income

$1M16.2% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+5.0%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$67,754

Balance Sheet

Total Assets

$58M

Total Liabilities

$54M

Stockholders' Equity

$4M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$8M	-8.5%
Gross Profit	$5M	$5M	-7.6%
Operating Income	$2M	$2M	+13.9%
Net Income	$1M	$953,338	+22.8%

Revenue Segments

Processing And Storage Fees

$7M99%

Public Banking

$46,3091%